In this study, we show for the first time that a novel formulation of curcumin with improved bioavailability improves cardiac function by suppressing NLRP3 inflammasome activation and mature IL-1β release in rat model of chronic kidney disease. Here, NLRP3 is linked to chronic kidney disease.